World News

Arsenic Trioxide in Combination with All-Trans Retinoic Acid for the Treatment...

Ogkologos - 3 Σεπτεμβρίου, 2025

177Lu-DOTATATE Shows Promising Efficacy in the Treatment of Patients with Progressive...

Ogkologos - 2 Σεπτεμβρίου, 2025

FDA Grants Accelerated Approval to Zongertinib for Non-squamous NSCLC with HER2...

Ogkologos - 29 Αυγούστου, 2025

Early-Stage and Locally Advanced NSCLC: ESMO Clinical Practice Guideline

Ogkologos - 28 Αυγούστου, 2025

Superior EFS and OS in Patients with Nonmetastatic Osteosarcoma and Unfavourable...

Ogkologos - 28 Αυγούστου, 2025

Molecular Analysis for Precision Oncology Congress 2025, Paris, France, 15-16 September

Ogkologos - 27 Αυγούστου, 2025

Combining Enzalutamide with Radium-223 Significantly Improves rPFS as First-Line Therapy for...

Ogkologos - 27 Αυγούστου, 2025

AI and remote monitoring are shaping a new patient journey in...

Ogkologos - 26 Αυγούστου, 2025

In Memory of Håkan Mellstedt: Former ESMO President

Ogkologos - 26 Αυγούστου, 2025

EMA Recommends Granting a Conditional Marketing Authorisation for Obecabtagene Autoleucel

Ogkologos - 26 Αυγούστου, 2025

1...404142...432 Σελίδα 41 από 432

MOST POPULAR

A Short-Course of Induction Chemotherapy Followed by Chemoradiotherapy Significantly Improves Survival...

31 Οκτωβρίου, 2024

Transforming Cancer Clinical Trials for Better, Faster Results

14 Απριλίου, 2023

Should People With Cancer Be Tested for Hepatitis B?

27 Ιουλίου, 2020

Nurse Diagnosed with Stage IV Cancer After Thinking Her Pain Was...

23 Μαρτίου, 2021

Φόρτωση περισσοτέρων

Arsenic Trioxide in Combination with All-Trans Retinoic Acid for the Treatment...

177Lu-DOTATATE Shows Promising Efficacy in the Treatment of Patients with Progressive...

FDA Grants Accelerated Approval to Zongertinib for Non-squamous NSCLC with HER2...

Early-Stage and Locally Advanced NSCLC: ESMO Clinical Practice Guideline

Superior EFS and OS in Patients with Nonmetastatic Osteosarcoma and Unfavourable...

Molecular Analysis for Precision Oncology Congress 2025, Paris, France, 15-16 September

Combining Enzalutamide with Radium-223 Significantly Improves rPFS as First-Line Therapy for...

AI and remote monitoring are shaping a new patient journey in...

In Memory of Håkan Mellstedt: Former ESMO President

EMA Recommends Granting a Conditional Marketing Authorisation for Obecabtagene Autoleucel

MOST POPULAR

A Short-Course of Induction Chemotherapy Followed by Chemoradiotherapy Significantly Improves Survival...

Transforming Cancer Clinical Trials for Better, Faster Results

Should People With Cancer Be Tested for Hepatitis B?

Nurse Diagnosed with Stage IV Cancer After Thinking Her Pain Was...

HOT NEWS

EMA Recommends Granting a Marketing Authorisation for Ripretinib for the Treatment...

Sacituzumab Govitecan Does Not Demonstrate a Statistically Significant OS Improvement in...

Breast Cancer Survivor Uses Comedy to Spread Awareness and Address Disparities

Adding Pirtobrutinib to Venetoclax-Rituximab Shows Significant Improvement in PFS Among Patients...

ΔΗΜΟΦΙΛΕΊΣ ΘΈΣΕΙΣ

ΚΑΡΚΙΝΟΣ ΘΥΜΟΥ ΑΔΕΝΑ (ΘΥΜΩΜΑ)

ΣΤΑΤΙΣΤΙΚΑ

ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ

ΔΗΜΟΦΙΛΗ ΚΑΤΗΓΟΡΙΑ